Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a sports gel power women through labor?

NCT ID NCT07742748

Disease control Sponsor: Institut Investigacio Sanitaria Pere Virgili Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 03, 2026 · Last updated Sep 10, 2026 · Updated 4 times

Summary

This pilot trial tests whether giving low-risk pregnant women a carbohydrate-rich sports gel during labor with epidural analgesia can improve outcomes compared to a low-sugar drink. The gel provides energy with low stomach volume, and is given every three hours after epidural placement until delivery. Researchers will measure labor duration, blood sugar levels, vomiting, bleeding, and maternal satisfaction. The goal is to gather preliminary data to inform a larger study.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
High carbohydrate sports gel
What this could lead to
If effective, this approach could shorten labor and improve maternal and neonatal outcomes, offering a simple dietary supplement to support women during childbirth.
What could go wrong
This is a small pilot study, so results may not be definitive. The gel could cause nausea or vomiting, and benefits may not be confirmed in larger trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 147 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnancy classified as Normal Pregnancy, Low-Risk Pregnancy, or Medium-Risk Pregnancy according to the "Protocol de seguiment de l'embaràs a Catalunya" and "Protocol de naixement i acompanyament al naixement de Catalunya". * Use of epidural analgesia during labor. * Ability to understand Catalan and/or Spanish. * Term pregnancy (≥37 weeks gestation). * Cephalic presentation. * Spontaneous onset of labor, OR induced labor due to prolonged pregnancy or premature rupture of membranes (regardless of duration). * Prenatal care at ASSIR Terres de l'Ebre with planned delivery at Hospital Universitari Tortosa Verge de la Cinta. * Signed informed consent prior to labor. Exclusion Criteria: * Gestational diabetes (including diet and exercise controlled). * Multiple gestation. * Labor not documented in partograph. * Informed consent not signed prior to labor. * Medical indication requiring administration of glucose or glucose-saline intravenous solution during labor (withdrawal criterion).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Energy metabolism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dystocia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Energy metabolism Labor nutrition Maternal outcomes Neonatal outcomes Obstetric labor

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • HUTVC

    RECRUITING

    Tortosa, Tarragona, 43500, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.